REQUEST A DEMO
Total
USD $0.00
Search more companies

Po Vyrobnytstvu Insuliniv Indar At (Ukraine)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Po Vyrobnytstvu Insuliniv Indar At Profile Updated: March 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Po Vyrobnytstvu Insuliniv Indar At is a company based in Ukraine, with its head office in Kyiv. It operates in the Medicinal and Botanical Manufacturing industry. The company was established on October 31, 1997. There are currently 349 (2021) people employed by Po Vyrobnytstvu Insuliniv Indar At. In Q12026, the company reported a net sales revenue increase of 26.21%. Its’ total assets recorded a growth of 3.15%. The net profit margin of Po Vyrobnytstvu Insuliniv Indar At decreased by 0.55% in 2026.

Headquarters
Bud. 5 Vul. Zroshuvalna
Kyiv; Kiev; Postal Code: 02099

Contact Details: Purchase the Po Vyrobnytstvu Insuliniv Indar At report to view the information.

Website: http://www.indar.com.ua

Basic Information
Total Employees:
Purchase the Po Vyrobnytstvu Insuliniv Indar At report to view the information.
Registered Capital:
Purchase the Po Vyrobnytstvu Insuliniv Indar At report to view the information.
Financial Auditors:
Purchase the Po Vyrobnytstvu Insuliniv Indar At report to view the information.
Incorporation Date:
October 31, 1997
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Po Vyrobnytstvu Insuliniv Indar At report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
26.21%
Total Operating Revenue
33.73%
Operating Profit
6.16%
EBITDA
-27.19%
Net Profit/Loss for the Period
6.05%
Total Assets
3.15%
Total Equity
1.57%
Operating Profit Margin
-0.67%
Net Profit Margin
-0.55%
Return on Equity (ROE)
0.07%
Quick Ratio
0.03%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?